Treatment with exogenous surfactant stimulates endogenous surfactant synthesis in premature infants with respiratory distress syndrome

OBJECTIVETreatment of preterm infants with respiratory distress syndrome (RDS) with exogenous surfactant has greatly improved clinical outcome. Some infants require multiple doses, and it has not been studied whether these large amounts of exogenous surfactant disturb endogenous surfactant metabolis...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Critical care medicine 2000-10, Vol.28 (10), p.3383-3388
Hauptverfasser:	Bunt, Jan Erik H, Carnielli, Virgilio P, Janssen, Daphne J, Wattimena, J L. Darcos, Hop, Wim C, Sauer, Pieter J, Zimmermann, Luc J. I
Format:	Artikel
Sprache:	eng
Schlagworte:	Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Anti-Inflammatory Agents - therapeutic use Biological and medical sciences Biological Products Blood Glucose - analysis Carbon Radioisotopes - administration & dosage Carbon Radioisotopes - metabolism Dexamethasone - therapeutic use Drug Therapy, Combination Ductus Arteriosus, Patent - complications Emergency and intensive care: neonates and children. Prematurity. Sudden death Gestational Age Humans Infant, Newborn Infusions, Intravenous Intensive care medicine Medical sciences Prospective Studies Pulmonary Surfactants - biosynthesis Pulmonary Surfactants - blood Pulmonary Surfactants - therapeutic use Regression Analysis Respiratory Distress Syndrome, Newborn - complications Respiratory Distress Syndrome, Newborn - drug therapy Respiratory Distress Syndrome, Newborn - metabolism Time Factors Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!